At the cellular level, psoriasis involves complex interactions between innate and adaptive immune systems, particularly through the interleukin-23 (IL-23)/IL-17 axis, leading to aberrant KC proliferation and inflammatory cascade activation [15,16,17]. The gene discussed is IL17A; the disease is psoriasis.